FIGX Capital Acquisition Corp.
NASDAQ:FIGXShell Companies
-$0.06 today
- Market cap
- $201.51M
- Beta
- 0.04
- P/E (TTM)
- 66.7
- EPS (TTM)
- $0.15
Volume 0.02M
Average 0.02M
FIGX EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
FIGX Capital Acquisition Corp.NASDAQ: FIGX
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA remains negative
Q1 FY2026 EBITDA was -$156.31K, compared with -$30.3K a year earlier.
Sources:Income StatementText generated from reported figures; not investment advice.
EBITDA history
Currency unavailable · from the income statement
No EBITDA data reported for this period type.
EBITDA vs competitors
How FIGX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
IBACIB Acquisition Corp. Common Stock | LTM Mar 2026 | -$82.32K USD | +85.8% | — | — |
RFAIRF Acquisition Corp II Ordinary Shares | LTM Mar 2026 | -$128.91K USD | -124.6% | — | — |
EGHAEGH Acquisition Corp. Class A Ordinary Shares | LTM Mar 2026 | -$273.9K USD | — | — | — |
INACIndigo Acquisition Corp. | LTM Mar 2026 | -$395.75K USD | — | — | — |
| LTM Sep 2025 | -$542.51K USD | -120.5% | +1792.1% | — | |
IPODDune Acquisition Corporation II | LTM Mar 2026 | -$989.8K USD | — | — | — |
TAVITavia Acquisition Corp. | LTM Mar 2026 | -$1.22M USD | -202.6% | — | — |
FIGXFIGX Capital Acquisition Corp. | — | — | — | — | — |
| Peer median (excluding FIGX) | — | -122.6% | +1792.1% | — | |
Competitors are the stored peer set for FIGX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
FIGX Capital Acquisition Corp.
NASDAQ:FIGX
Intrinsic Alpha fair value
Locked
Current Price
$10.40
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.